BDBM676758 2-[(11R,15S)-13,16-dioxa-2,4,10-triazatetracyclo[7.7.0.0{}{3,7}.0{}{11,15}]hexadeca-1(9),2,5,7-tetraen-10-yl]-4-{2-[(3S)-3-(2-methylphenyl)-1,4-oxazepan-4-yl]-7-azaspiro[3.5]nonan-7-yl}-N-{3-nitro-4-[(oxan-4-ylmethyl)amino]benzenesulfonyl}benzamide::US20240166646, Example 66

SMILES Cc1ccccc1[C@H]1COCCCN1C1CC2(C1)CCN(CC2)c1ccc(C(=O)NS(=O)(=O)c2ccc(NCC3CCOCC3)c(c2)[N+]([O-])=O)c(c1)N1[C@@H]2COC[C@H]2Oc2nc3[nH]ccc3cc12

InChI Key InChIKey=FPPDGAPCWDLGBX-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 676758   

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandPNGBDBM676758(2-[(11R,15S)-13,16-dioxa-2,4,10-triazatetracyclo[7...)
Affinity DataIC50: 0.564nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2024
Entry Details
Go to US Patent